Recent Finacing
Recent Raise
Toralgen develops a poly-bile nanoparticle "nanopill" platform for oral delivery of biologics, advancing preclinical diabetes and autoimmune candidates and engaging with FDA’s Emerging Technology Program.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Toralgen.
